Literature DB >> 8137683

Ethnic differences in human leukocyte antigen markers of susceptibility to IDDM.

K J Cruickshanks1, L F Jobim, J Lawler-Heavner, T G Neville, E C Gay, H P Chase, G Klingensmith, J A Todd, R F Hamman.   

Abstract

OBJECTIVE: To determine whether genetic differences explain the lower risk of developing insulin-dependent diabetes mellitus (IDDM) for Hispanic versus non-Hispanic white children in Colorado. RESEARCH DESIGN AND METHODS: Hispanic (n = 62) and non-Hispanic white (n = 82) subjects with IDDM identified from the Colorado IDDM Registry and healthy, nondiabetic control subjects were recruited. Human leukocyte antigen (HLA) serologic typing and sequence-specific oligonucleotide typing of DQA1 and DQB1 alleles were performed.
RESULTS: HLA and allele associations with IDDM were similar in both ethnic groups. HLA-DR3 and HLA-DR4 were more common in IDDM subjects in both ethnic groups. Subjects with DQBl alleles encoding aspartic acid (Asp) in position 57 were less likely to have IDDM, irrespective of ethnic background. HLA-DR3 was less common among Hispanic subjects than non-Hispanic white control subjects (4.4 vs. 17.5%, Hispanics vs. non-Hispanic whites, P = 0.04).
CONCLUSIONS: These data suggest that the lower prevalence of HLA-DR3 in the Hispanic population, a pattern consistent with the presence of Amerindian admixture, may explain the lower rate of IDDM in the Hispanic population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137683     DOI: 10.2337/diacare.17.2.132

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

Review 1.  Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis.

Authors:  Maria J Redondo; Richard A Oram; Andrea K Steck
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

Review 2.  Genetics of type 1 diabetes.

Authors:  Maria J Redondo; Andrea K Steck; Alberto Pugliese
Journal:  Pediatr Diabetes       Date:  2017-11-02       Impact factor: 4.866

3.  Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates.

Authors:  Lisa M Emery; Sunanda Babu; Teodorica L Bugawan; Jill M Norris; Henry A Erlich; George S Eisenbarth; Marian Rewers
Journal:  Pediatr Diabetes       Date:  2005-09       Impact factor: 4.866

4.  Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

Authors:  M Rewers; T L Bugawan; J M Norris; A Blair; B Beaty; M Hoffman; R S McDuffie; R F Hamman; G Klingensmith; G S Eisenbarth; H A Erlich
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 5.  Clinical and research uses of genetic risk scores in type 1 diabetes.

Authors:  Seth A Sharp; Michael N Weedon; William A Hagopian; Richard A Oram
Journal:  Curr Opin Genet Dev       Date:  2018-04-24       Impact factor: 5.578

6.  Categorization of humans in biomedical research: genes, race and disease.

Authors:  Neil Risch; Esteban Burchard; Elad Ziv; Hua Tang
Journal:  Genome Biol       Date:  2002-07-01       Impact factor: 13.583

7.  Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes.

Authors:  Kendra Vehik; Richard F Hamman; Dennis Lezotte; Jill M Norris; Georgeanna J Klingensmith; Marian Rewers; Dana Dabelea
Journal:  Diabetes Care       Date:  2008-03-20       Impact factor: 19.112

8.  Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.

Authors:  H C Lee; B S Cha; M S Nam; Y D Song; S K Lim; D H Kim; K B Huh; Y Koh
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.